查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529863

荷爾蒙避孕藥市場規模、佔有率、趨勢分析報告：依方法、按荷爾蒙、按地區、細分市場預測，2024-2030

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, IUD), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

荷爾蒙避孕藥市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球荷爾蒙避孕藥市場規模將達到212.1億美元，2024年至2030年複合年成長率為4.01%。

市場成長預計將由創新產品的推出和新興地區生殖健康意識的提高所推動。在新興經濟體，由於政府措施和計畫的增加，越來越多的女性開始使用避孕器，預計將加速市場成長。例如，根據聯合國《2022年世界生育和計劃生育報告》，到2021年，19億育齡婦女將使用某種形式的避孕措施來避免懷孕，其中77%的婦女植入、貼片或子宮內節育器。

根據聯合國人口基金會 (UNFPO) 的《2022 年世界人口狀況》，全球整體每年 1.21 億例懷孕中，約有 50% 是意外懷孕。根據《看到未見之事：在被忽視的意外懷孕危機中採取行動的案例》，超過60% 的意外懷孕以墮胎告終；因此，為了避免不安全墮胎，各國正在傳播避孕措施的意識，這是預期的結果。

由於市場競爭激烈，企業在研發方面投入大量資金。我們也採取多種策略，包括併購和擴大產品平臺。例如，2022年2月，歐加農集團從拜耳公司收購了口服荷爾蒙每日避孕藥Mercilon和Marvelon在中華人民共和國（包括澳門和香港）的權利。此外，我們已同意在越南取得這些產品的權利。此次收購旨在獲得全球（不包括韓國）這些品牌的所有權。

荷爾蒙避孕市場報告亮點

  • 從某種程度上來說，藥物在 2023 年佔據了市場主導地位。這是由於高效且簡單的劑量、現成的產品、由於與長效可逆裝置相比較早推出而提高的市場認知度、正確使用的約99% 的功效以及眾多的原因。存在有助於成長領域。
  • 以荷爾蒙來看，由於副作用較少且出現痤瘡及相關症狀的機會較小，複合荷爾蒙避孕藥將在 2023 年佔據市場主導地位。
  • 2023年北美地區佔最大市場佔有率。這是由於大公司的存在、意外懷孕率高、人均收入高、政府的支持措施。
  • 2023 年 6 月，製藥公司 Gedeon Richter UK Limited 以 3,517 萬美元（3,250 萬歐元）從 Consilient Health Ltd. 收購了品牌非專利藥避孕藥的全部行銷和分銷權。此次收購旨在以實惠的價格在英國各地提供該產品。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 波特五力分析
    • PESTLE分析

第 4 章業務分析：按方法

  • 2023 年和 2030 年按方法市場佔有率
  • 按方法細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析（依方法）
  • 丸
    • 2018-2030 年藥品市場估計與預測
  • IUD
    • 2018-2030 年子宮內避孕器市場估計與預測
  • 注射
    • 2018-2030 年注射藥品市場估計與預測
  • 避孕環
    • 2018-2030 年避孕環市場估計與預測
  • 植入
    • 2018-2030 年植入市場估計與預測
  • 修補
    • 2018-2030 年補丁市場估計與預測

第5章業務分析：依荷爾蒙分類

  • 2023 年和 2030 年市場佔有率
  • 荷爾蒙細分儀表板
  • 2018-2030年荷爾蒙市場規模及預測與趨勢分析
  • 合併荷爾蒙避孕
    • 2018-2030 年聯合荷爾蒙避孕藥市場估計與預測
  • 僅孕激素
    • 2018-2030 年純黃體素市場估計與預測

第 6 章 按方法和類型分類的區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 2018-2030 年北美荷爾蒙避孕藥市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲荷爾蒙避孕藥市場估計與預測
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區荷爾蒙避孕藥市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲激素避孕藥市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲荷爾蒙避孕市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/名單
    • AbbVie Inc.
    • Bayer AG
    • Organon group of companies.
    • Pfizer Inc.
    • Afaxys, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Agile Therapeutics
    • Johnson &Johnson Services, Inc.
    • Lupin Pharmaceuticals, Inc.
    • Pregna International Limited.
Product Code: GVR-2-68038-348-5

Hormonal Contraceptive Market Growth & Trends:

The global hormonal contraceptive market size is anticipated to reach USD 21.21 billion by 2030, growing at a CAGR of 4.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is expected to be driven by the introduction of innovative products and increasing awareness about reproductive health in emerging regions. More women in developing economies are using contraceptives due to the rise in government initiatives and programs, which is anticipated to accelerate market growth. For instance, according to the UN World Fertility and Family Planning 2022, in 2021, 1.9 billion women of reproductive age received some form of contraception to avoid pregnancy with 77% of women among them using modern contraceptive methods including implants, patches, IUDs, and others.

According to the State of World Population 2022, by UNFPO, globally, approximately 50% of all 121 million pregnancies each year are unwanted. As per the Seeing the Unseen report: The case for action in the neglected crisis of unintended pregnancy, more than 60% of unwanted pregnancies result in abortion and the projected 45% among them are unsafe. Hence, to avoid unsafe abortions, countries are spreading awareness about contraceptives, which is expected to propel industry growth.

Due to the highly competitive nature of the market, companies are making significant investments in research and development. They are also adopting various strategies such as mergers and acquisitions and expanding their product pipelines. For instance, in February 2022, Organon Group of Companies acquired rights of Mercilon and Marvelon, combined oral hormonal daily contraceptive pills from Bayer AG in the People's Republic of China, including Macau and Hong Kong. In addition, it has agreed to acquire rights in Vietnam to these products. This acquisition aims to provide global ownership rights of these brands, except in South Korea.

Hormonal Contraceptive Market Report Highlights:

  • Based on method, the pill segment dominated the market in 2023 owing to the efficient and straightforward administration, readily accessible products, enhanced market awareness due to early introduction compared to long-acting reversible devices, and an approximate 99% effectiveness with proper usage, and the presence of many players contribute to the segment growth.
  • Based on hormone, the combination hormonal contraceptive segment dominated the market in 2023 owing to the fewer side effects and lower chances of developing acne and related symptoms.
  • North America region held the largest market share in 2023. This can be attributed to the existence of major players, a high proportion of unwanted pregnancies, high per capita income, and supportive government initiatives.
  • In June 2023, Gedeon Richter UK Limited, a pharmaceutical company, acquired full distribution and marketing rights of a contraceptive range of branded generics from Consilient Health Ltd. for USD 35.17 million (Euro 32.5 million). This acquisition aims to provide this product at affordable prices across the UK.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Method
    • 1.2.2. Hormone
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
    • 1.8.2. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in government and NGO initiatives to promote contraceptive methods
      • 3.2.1.2. High unmet needs
      • 3.2.1.3. Increasing R&D investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Rapidly aging population and rising prevalence of infertility
      • 3.2.2.2. Adverse effects associated with the use of contraceptive drugs and devices
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Method Business Analysis

  • 4.1. Method Market Share, 2023 & 2030
  • 4.2. Method Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 4.4. Pill
    • 4.4.1. Pill market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. IUD
    • 4.5.1. IUD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Injectable
    • 4.6.1. Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Vaginal Ring
    • 4.7.1. Vaginal ring market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Implant
    • 4.8.1. Implant market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Patch
    • 4.9.1. Patch market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hormone Business Analysis

  • 5.1. Hormone Market Share, 2023 & 2030
  • 5.2. Hormone Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, by Hormone, 2018 to 2030 (USD Million)
  • 5.4. Combination Hormonal Contraceptives
    • 5.4.1. Combination hormonal contraceptives market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Progestin Only
    • 5.5.1. Progestin only market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis by Method & Type

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 6.4. North America
    • 6.4.1. North America hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. U.S. hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Canada hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Mexico hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. UK hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. France hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Italy hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Spain hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Denmark hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Sweden hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Norway hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Japan hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. China hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. India hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Australia hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Thailand hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Brazil hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. Argentina hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. South Africa hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Saudi Arabia hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. UAE hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive scenario
      • 6.8.5.4. Kuwait hormonal contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Organon group of companies.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Pfizer Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Afaxys, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Teva Pharmaceutical Industries Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Agile Therapeutics
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Johnson & Johnson Services, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Lupin Pharmaceuticals, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Pregna International Limited.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 4 Global hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 5 Global hormonal contraceptive market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 8 North America hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 9 U.S hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 10 U.S hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 11 Canada hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 12 Canada hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 13 Mexico hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 14 Mexico hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 15 Europe hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 17 Europe hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 18 UK hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 19 UK hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 20 Germany hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 21 Germany hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 22 France hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 23 France hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 24 Italy hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 25 Italy hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 26 Spain hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 27 Spain hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 28 Norway hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 29 Norway hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 30 Sweden hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 31 Sweden hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 32 Denmark hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 33 Denmark hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 37 Japan hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 38 Japan hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 39 China hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 40 China hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 41 India hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 42 India hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 43 Australia hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 44 Australia hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 45 South Korea hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 46 South Korea hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 47 Thailand hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 48 Thailand hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 49 Latin America hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 51 Latin America hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 52 Brazil hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 53 Brazil hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 54 Argentina hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 55 Argentina hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa hormonal contraceptive market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 59 South Africa hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 60 South Africa hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 63 UAE hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 64 UAE hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)
  • Table 65 Kuwait hormonal contraceptive market, by method, 2018 - 2030 (USD Million)
  • Table 66 Kuwait hormonal contraceptive market, by hormone, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's Five Forces analysis
  • Fig. 16 Hormonal contraceptive market: Method outlook and key takeaways
  • Fig. 17 Hormonal contraceptive market: Method movement analysis
  • Fig. 18 Pill market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 IUD market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Injectable market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 Vaginal ring market revenue, 2018 - 2030 (USD Million)
  • Fig. 22 Implant market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Patch market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Hormonal contraceptive market: Hormone outlook and key takeaways
  • Fig. 25 Hormonal contraceptive market: Hormone movement analysis
  • Fig. 26 Combined hormone contraceptive market revenue, 2018 - 2030 (USD Million)
  • Fig. 27 Progestin only market revenue, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2023 & 2030
  • Fig. 30 Hormonal contraceptive market: Region movement analysis
  • Fig. 31 North America hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 32 US hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Sweden hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Asia Pacific hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Latin America hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Middle East and Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait hormonal contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Company categorization
  • Fig. 83 Strategy mapping
  • Fig. 84 Company market position analysis